Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 1Neoplasms 1

Interventions

Paclitaxel 39Specimen Handling 32Carboplatin 32pembrolizumab 31Bevacizumab 24Magnetic Resonance Spectroscopy 23Gemcitabine 15Biopsy 15liposomal doxorubicin 14olaparib 13Cisplatin 11Nivolumab 9Doxorubicin 9Topotecan 8Taxes 8Cyclophosphamide 8fludarabine 7palbociclib 6Surveys and Questionnaires 6Fulvestrant 6lenvatinib 5abemaciclib 5X-Rays 5Immunoglobulin G 5Docetaxel 5Disulfides 51-dodecylpyridoxal 5trastuzumab deruxtecan 4mirvetuximab soravtansine 4dostarlimab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FAPI-46 × Gynecologic × 30 days × Clear all
NCT05903807 2026-05-27

[68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer

Aalborg University Hospital

Phase 2 Terminated
20 enrolled
Gynecologic

Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡